Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles - PubMed
The protease inhibitor leupeptin decreases protein degradation in rat skeletal and cardiac muscle incubated in vitro, while protein synthesis remains unaltered. Leupeptin also lowers protein breakdown in denervated rat muscles and affected muscles from mice with hereditary muscular dystrophy. Leupep …
Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles - PubMed Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Access keys NCBI Homepage MyNCBI Homepage Ma
Explore this link on the map →related reading
- Longevity FAQ - Laura Demingldeming.com
- Protein degradation reaches further outnature.com
- Engineering Plastic-Degrading Enzymes and PCSK9 Binders with Protein AI Toolsblog.latch.bio
- Four grams of glucose - PMCncbi.nlm.nih.gov
- Lysosome-targeting chimaeras for degradation of extracellular proteins | Naturenature.com
- Lysosome-targeting chimeras evolve | Nature Chemical Biologynature.com
- ALS - Wikipediaen.wikipedia.org
- Myotonic Dystrophy: What It Is, Symptoms, Types & Treatmentmy.clevelandclinic.org
- TNIK | Insilico Medicineinsilico.com
- Peptidein - Wikipediaen.wikipedia.org
- Dietary protein intake and human health - PubMedpubmed.ncbi.nlm.nih.gov
- Research Areas - Svendsen Lab | Cedars-Sinaicedars-sinai.edu